Glucose sensor and uses thereof

• US 20030232370A1
• Filed: 04/22/2003
• Published: 12/18/2003
• Est. Priority Date: 04/22/2002
• Status: Abandoned Application

• Current Assignee: McGill University
• Original Assignee: McGill University
• Inventors: Trifiro, Mark A.
• Application Number:
  US10/421,360
• Publication Number:
  US 20030232370A1
• Time in Patent Office: Days
• US Class Current: 435/6.13
• CPC Class Codes: C12N 9/1205 Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
• CPC Class Codes: C12Y 207/01001 Hexokinase (2.7.1.1)

Abstract

The present invention provides a glucokinase protein in which the catalytic activity has been disabled in order to enable its use as a glucose sensor. The catalytically disabled glucokinase protein can be used as the glucose sensor in hand-held glucose monitors and in implantable glucose monitoring devices. The glucose sensor can also be incorporated into biomedical devices for the continuous monitoring of glucose and administration of insulin.

Claims

1. A recombinant human glucokinase having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase.

2. The recombinant glucokinase according to claim 1 comprising a mutation at one or more residue selected from the group of:

Asp78, Gly81, Thr82, Asn83, Arg85, Ser 151, Thr 168, Lys169, Asn204, Asp205, Thr228, Asn231, Glu256, Glu290, Lys296, Thr332, Ser336, Ser411 and Lys414.

3. The recombinant glucokinase according to claim 1, wherein said human glucokinase is the human liver glucokinase isoform 2.

4. The recombinant glucokinase according to claim 1, wherein said decreased catalytic activity is between about 10 and about 10 000-fold less than the catalytic activity of the corresponding wild-type human glucokinase.

5. The recombinant glucokinase according to claim 2, wherein said one or more mutation is at residue Asp205.

6. The recombinant glucokinase according to claim 2, wherein said one or more mutation is at residue Ser336.

7. The recombinant glucokinase according to claim 2, comprising mutations at residues Asp205 and Ser336.

8. The recombinant glucokinase according to claim 5, wherein the mutation is Asp205Ala.

9. The recombinant glucokinase according to claim 6, wherein the mutation is Ser336Val, Ser336Leu or Ser336Ile.

10. An isolated nucleic acid molecule encoding a mutant human glucokinase having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase.

11. The isolated nucleic acid according to claim 10, wherein said mutant glucokinase comprises a mutation at one or more residue selected from the group of:

Asp78, Gly81, Thr82, Asn83, Arg85, Ser151, Thr 168, Lys169, Asn204, Asp205, Thr228, Asn231, Glu256, Glu290, Lys296, Thr332, Ser336, Ser411 and Lys414.

12. The isolated nucleic acid according to claim 10, wherein said human glucokinase is the human liver glucokinase isoform 2.

13. The isolated nucleic acid according to claim 11, wherein said mutation is at residue Asp205.

14. The isolated nucleic acid according to claim 11, wherein said mutation is at residue Ser336.

15. The isolated nucleic acid according to claim 11, comprising mutations at residues Asp205 and Ser336.

16. The isolated nucleic acid according to claim 13, wherein the mutation is Asp205Ala.

17. The isolated nucleic acid according to claim 14, wherein the mutation is Ser336Val, Ser336Leu or Ser336Ile.

18. A vector comprising the isolated nucleic acid molecule according to claim 10.

19. The vector according to claim 18, wherein said nucleic acid molecule is operably linked to a regulatory control sequence.

20. A host cell comprising the vector according to claim 18.

21. A method of producing a recombinant human glucokinase comprising:

(a) culturing the host cell according to claim 20 under conditions in which the encoded glucokinase is expressed; and

(b) isolating the expressed glucokinase.

22. A glucose sensor comprising a recombinant human glucokinase having decreased catalytic activity but a substantially identical ability to bind glucose relative to the corresponding wild-type human glucokinase.

23. The glucose sensor according to claim 22, wherein said recombinant glucokinase is immobilised on a solid support.

24. The glucose sensor according to claim 22, wherein said glucose sensor is implantable.

25. A method of determining the level of glucose in a sample comprising:

(a) contacting said sample with a recombinant human glucokinase having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase;

(b) measuring a change in a physical characteristic of said recombinant glucokinase; and

(c) correlating said change to the level of glucose in said sample.

26. The method according to claim 25, wherein said contacting and said measuring are conducted in vivo.

27. The method according to claim 25, wherein said measuring is conducted on a continuous basis thereby providing a continuous determination of the level of glucose in said sample.